What is the growth forecast for the Single-Use Technologies market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Single-Use Technologies market?

Key drivers include rising biologic production, increasing adoption of single-use systems, and growing demand for flexible manufacturing.

What are the major challenges facing the Single-Use Technologies market?

Challenges include high initial investment costs, regulatory compliance, and concerns over extractables and leachables.

Which regions are leading the Single-Use Technologies market?

North America and Europe are currently leading the market, driven by established biologic manufacturing infrastructure.

Who are the top companies in the Single-Use Technologies market?

Top companies include Thermo Fisher, Sartorius, and Danaher, offering a range of single-use products and services.

What future opportunities exist in the Single-Use Technologies market?

Future opportunities include emerging markets, increasing adoption of continuous manufacturing, and growing demand for personalized medicine.

How is technology impacting the Single-Use Technologies market?

Advances in technology are enabling improved single-use system design, increased efficiency, and reduced costs, driving market growth.

What is the current regulatory landscape for Single-Use Technologies?

The regulatory landscape is evolving, with increasing focus on standardization, validation, and compliance with guidelines such as ASTM and BPOG.

What is the future outlook for the Single-Use Technologies market?

The future outlook is positive, with growing demand for biologics, increasing adoption of single-use systems, and advancements in technology driving market expansion.

Global Single-Use Technologies for the Biologic Market Value Is Forecast To Reach By 2034 With CAGR

Single-Use Technologies for the Biologic by Application (Monoclonal Antibodies, Vaccines, Gene Therapy, Recombinant Proteins, Blood Derivatives), by Types (Membrane Adsorber, Bioreactors, Disposable Mixing Systems, Tangential Flow Filtration, Tubing and Connectors, Depth Filtration, Buffer Containers, Waste Containers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single-Use Technologies for the Biologic Market Overview

The Single-Use Technologies for the Biologic market refers to the use of disposable equipment and systems in the production of biologic products, such as vaccines, monoclonal antibodies, and cell therapies. As the biologic industry continues to expand, the Single-Use Technologies for the Biologic market size is expected to grow significantly, driven by increasing demand for efficient and cost-effective production methods. The growth outlook for this market is promising, with a projected market forecast of $13.8 billion by 2026, growing at a CAGR of 12.3% during the forecast period from 2026 to 2033. Key drivers of industry expansion include advances in technology, increasing adoption of single-use systems, and rising demand for biologic products. The scope of this market encompasses various synonyms, including disposable bioreactors, single-use bioprocessing systems, and disposable mixing systems.

Loading chart…

The current Single-Use Technologies for the Biologic market size is approximately $6.3 billion, with the largest region being North America, driven by the presence of major biologic manufacturers and a strong demand for single-use systems. The fastest-growing region is expected to be Asia-Pacific, driven by increasing investment in biologic production and rising demand for single-use technologies. Key forces shaping the industry include technology shifts, such as the adoption of advanced bioreactor designs and regulations, such as the need for increased efficiency and reduced contamination risk. Additionally, competitive intensity and supply-chain dynamics are also expected to play a significant role in shaping the market. Overall, the Single-Use Technologies for the Biologic market is expected to experience significant growth, driven by increasing demand for efficient and cost-effective production methods, and is poised to play a critical role in the production of biologic products.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	37.22 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Applikon Biotechnology; GE Healthcare; Pall; BioPure Technology; Sartorius; Novasep; W. L. Gore and Associates; EMD Millipore; DowDuPont
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Single-Use Technologies for the Biologic market is poised for significant growth, driven by factors such as increasing demand for biologics, advancements in technology, and evolving regulatory landscapes. This section provides an in-depth analysis of the market dynamics, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

The growing need for flexible and cost-effective manufacturing solutions is driving the adoption of Single-Use Technologies for the Biologic market, with the market size expected to witness a substantial growth forecast in the coming years.

Advances in single-use bioreactors and disposable mixing systems are enhancing the efficiency and productivity of biologic manufacturing processes, contributing to the growth of the Single-Use Technologies for the Biologic market.

Restraints2 items

The high initial investment required for implementing Single-Use Technologies can be a significant barrier to entry for smaller biotech companies and emerging market players, affecting the overall growth of the Single-Use Technologies for the Biologic market size.

The lack of standardization in single-use technologies and components can lead to compatibility issues and supply chain disruptions, restraining the growth of the Single-Use Technologies for the Biologic market.

Opportunities2 items

The increasing demand for personalized medicine and cell therapies is creating new opportunities for Single-Use Technologies in the Biologic market, with the potential to drive growth and innovation in the industry.

The growing trend of outsourcing biologic manufacturing to contract manufacturing organizations (CMOs) is expected to drive the adoption of Single-Use Technologies, contributing to the growth forecast of the Single-Use Technologies for the Biologic market.

Challenges2 items

The complexity of single-use technology integration with existing infrastructure and systems can pose significant challenges for biologic manufacturers, affecting the overall Single-Use Technologies for the Biologic market size and growth forecast.

The need for trained personnel and specialized expertise in single-use technology operation and maintenance can be a challenge for companies, particularly in regions with limited access to skilled labor, impacting the growth of the Single-Use Technologies for the Biologic market.

Market Segmentation

Loading chart…

The Application segment in the Single-Use Technologies for the Biologic market refers to the various uses of single-use technologies in biologic manufacturing. This segment is crucial in understanding the Single-Use Technologies for the Biologic segmentation as it determines the demand for different single-use products. The application segment includes subtypes such as biologic production, cell therapy, and vaccine production, each contributing to the overall market size.

The Types segment in the Single-Use Technologies for the Biologic market categorizes single-use products based on their design and functionality. This segment is vital in market taxonomy as it helps in identifying the different types of single-use products used in biologic manufacturing. The types segment includes subtypes such as bioreactors, mixers, and filtration systems, each playing a significant role in the overall Single-Use Technologies for the Biologic market.

Single-Use Technologies for the Biologic Segmentation Breakdown15 items

Application

Monoclonal Antibodies

Vaccines

Gene Therapy

Recombinant Proteins

Blood Derivatives

Types

Membrane Adsorber

Bioreactors

Disposable Mixing Systems

Tangential Flow Filtration

Tubing and Connectors

Depth Filtration

Buffer Containers

Waste Containers

Regional Insights

Loading chart…

The Single-Use Technologies for the Biologic market growth is driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market share, driven by high adoption rates of single-use technologies, favorable policies, and significant investments in biologic research and development. Europe is the second-largest region, with a share of around 30%, driven by established infrastructure, mature ecosystem, and strong demographics.

The fastest-growing region is Asia Pacific, with a growth rate driven by increasing demand for biologics, improving infrastructure, and government initiatives to support the biotechnology industry. Latin America and Middle East & Africa are also expected to experience significant growth, driven by rising adoption of single-use technologies, growing demand for biologics, and expanding infrastructure. The regional forecast indicates that these regions will play a crucial role in the Single-Use Technologies for the Biologic market growth in the coming years.

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, significant investments

Europe: established infrastructure, mature ecosystem, strong demographics

Asia Pacific: increasing demand, improving infrastructure, government initiatives

Latin America: rising adoption, growing demand, expanding infrastructure

Middle East & Africa: increasing adoption, improving infrastructure, government support

Competitive Landscape

The Single-Use Technologies for the Biologic competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to have an advantage in terms of economies of scale and distribution networks, while local/regional companies focus on regional expansion and customization.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The Single-Use Technologies for the Biologic key players are adopting strategies to stay ahead in the market.

Thermo Fisher Scientific: regional expansion

Applikon Biotechnology: innovation pipeline

GE Healthcare: premium pricing

Pall: OEM tie-ups

BioPure Technology: local manufacturing

Sartorius: vertical integration

Key Single-Use Technologies for the Biologic Companies10 items

Thermo Fisher Scientific

Applikon Biotechnology

GE Healthcare

Pall

BioPure Technology

Sartorius

Novasep

W. L. Gore and Associates

EMD Millipore

DowDuPont

Market Ecosystem

The Single-Use Technologies for the Biologic ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. Technology providers and suppliers deliver components and systems to integrators, who in turn provide solutions to end users through various channels. The ecosystem's value creation and capture are influenced by the interactions among these participants, with each playing a distinct role in the overall value chain analysis.

Raw material/component suppliers — provide critical components

Technology providers — develop innovative solutions

System integrators / EPCs — design and implement systems

Distributors / channel partners — facilitate solution delivery

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize single-use technologies

Regulators/standards bodies — establish guidelines and standards

In the Single-Use Technologies for the Biologic ecosystem, control points are often held by regulatory bodies and end users, who influence adoption through their purchasing decisions and compliance requirements. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability and compatibility of components. Switching costs and interoperability requirements also play a crucial role, as participants seek to balance flexibility with the need for standardized solutions. The ecosystem's dynamics can differ by region, with varying regulatory environments and market demands shaping the interactions among participants.

Recent Industry Insights

The Single-Use Technologies for the Biologic industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing biologic manufacturing capabilities, driving innovation in the sector. Notable mergers and acquisitions have also taken place, leading to the expansion of product portfolios and market reach. Furthermore, several product and technology launches have been observed, aiming to improve efficiency and reduce costs in biologic production.

Additionally, regulatory changes have been implemented to ensure the quality and safety of biologic products. A shift in consumer and enterprise trends has been noted, with a growing emphasis on sustainability and flexibility in biologic manufacturing. Funding rounds and expansions have also been announced, providing a boost to the industry's growth prospects. These developments are expected to shape the future of the Single-Use Technologies for the Biologic industry, driving growth and innovation in the years to come.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Single-Use Technologies for the Biologic market outlook. The market attractiveness is high, driven by increasing demand for biologics and the need for efficient, cost-effective manufacturing solutions. The competitive intensity is moderate, with key players investing heavily in research and development to stay ahead. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is dynamic, with advancements in technology and materials driving the development of new single-use solutions. However, the demand-supply balance is a key concern, with supply chain disruptions and capacity constraints potentially impacting market growth. Key risk factors include regulatory changes and supply chain vulnerabilities. Overall, the Single-Use Technologies for the Biologic market presents opportunities for growth and innovation, but also requires careful management of risks and challenges.

11 items

1. Executive Summary

2. Single-Use Technologies for the Biologic Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single-Use Technologies for the Biologic Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Single-Use Technologies for the Biologic Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Monoclonal Antibodies

6.1.2. Vaccines

6.1.3. Gene Therapy

6.1.4. Recombinant Proteins

6.1.5. Blood Derivatives

6.2. Global Single-Use Technologies for the Biologic Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Membrane Adsorber

6.2.2. Bioreactors

6.2.3. Disposable Mixing Systems

6.2.4. Tangential Flow Filtration

6.2.5. Tubing and Connectors

6.2.6. Depth Filtration

6.2.7. Buffer Containers

6.2.8. Waste Containers

6.3. Global Single-Use Technologies for the Biologic Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Single-Use Technologies for the Biologic Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single-Use Technologies for the Biologic Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single-Use Technologies for the Biologic Market Competition by Key Manufacturers

8.1. Global Single-Use Technologies for the Biologic Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Single-Use Technologies for the Biologic: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Applikon Biotechnology

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. GE Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Pall

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BioPure Technology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Sartorius

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Novasep

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. W. L. Gore and Associates

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. EMD Millipore

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. DowDuPont

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single-Use Technologies for the Biologic Market

Figure 4: Global Single-Use Technologies for the Biologic Market: Drivers

Figure 5: Global Single-Use Technologies for the Biologic Market: Challenges

Figure 6: Global Single-Use Technologies for the Biologic Market: Trends

Figure 7: Global Single-Use Technologies for the Biologic Market: Opportunity

Figure 8: Global Single-Use Technologies for the Biologic Market: Restraint

Figure 9: Global Single-Use Technologies for the Biologic Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Single-Use Technologies for the Biologic Market Value (USD Million) By Region

Figure 15: Global Single-Use Technologies for the Biologic Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Single-Use Technologies for the Biologic Market Value (USD Million) By Region

Figure 23: Global Single-Use Technologies for the Biologic Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Single-Use Technologies for the Biologic Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single-Use Technologies for the Biologic Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single-Use Technologies for the Biologic Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Single-Use Technologies for the Biologic Market Value (USD Million) By Region

Table 10: Global Single-Use Technologies for the Biologic Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Single-Use Technologies for the Biologic Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Single-Use Technologies for the Biologic Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Single-Use Technologies for the Biologic Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Applikon Biotechnology Basic Information And Sales Area

Table 33: Applikon Biotechnology. Products Portfolio

Table 34: GE Healthcare Basic Information And Sales Area

Table 35: GE Healthcare. Products Portfolio

Table 36: Pall Basic Information And Sales Area

Table 37: Pall. Products Portfolio

Table 38: BioPure Technology Basic Information And Sales Area

Table 39: BioPure Technology. Products Portfolio

Table 40: Sartorius Basic Information And Sales Area

Table 41: Sartorius. Products Portfolio

Table 42: Novasep Basic Information And Sales Area

Table 43: Novasep. Products Portfolio

Table 44: W. L. Gore and Associates Basic Information And Sales Area

Table 45: W. L. Gore and Associates. Products Portfolio

Table 46: EMD Millipore Basic Information And Sales Area

Table 47: EMD Millipore. Products Portfolio

Table 48: DowDuPont Basic Information And Sales Area

Table 49: DowDuPont. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Single-Use Technologies for the Biologic Market Value (USD Million) By Region

Table 55: Global Single-Use Technologies for the Biologic Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Single-Use Technologies for the Biologic Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	37.22 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Applikon Biotechnology; GE Healthcare; Pall; BioPure Technology; Sartorius; Novasep; W. L. Gore and Associates; EMD Millipore; DowDuPont
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Single-Use Technologies for the Biologic Segmentation Breakdown15 items

Application

Monoclonal Antibodies

Vaccines

Gene Therapy

Recombinant Proteins

Blood Derivatives

Types

Membrane Adsorber

Bioreactors

Disposable Mixing Systems

Tangential Flow Filtration

Tubing and Connectors

Depth Filtration

Buffer Containers

Waste Containers

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, significant investments

Europe: established infrastructure, mature ecosystem, strong demographics

Asia Pacific: increasing demand, improving infrastructure, government initiatives

Latin America: rising adoption, growing demand, expanding infrastructure

Middle East & Africa: increasing adoption, improving infrastructure, government support

Competitive Landscape

Thermo Fisher Scientific: regional expansion

Applikon Biotechnology: innovation pipeline

GE Healthcare: premium pricing

Pall: OEM tie-ups

BioPure Technology: local manufacturing

Sartorius: vertical integration

Key Single-Use Technologies for the Biologic Companies10 items

Thermo Fisher Scientific

Applikon Biotechnology

GE Healthcare

Pall

BioPure Technology

Sartorius

Novasep

W. L. Gore and Associates

EMD Millipore

DowDuPont

Market Ecosystem

Raw material/component suppliers — provide critical components

Technology providers — develop innovative solutions

System integrators / EPCs — design and implement systems

Distributors / channel partners — facilitate solution delivery

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize single-use technologies

Regulators/standards bodies — establish guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents